DeepChek® Assay INTEGRASE Genotyping and Drug Resistance
The DeepChek® Assay -HIV Integrase Genotyping and Drug Resistance is intended to be used for HIV-1 genotyping and provides antiretroviral susceptibility information for protease inhibitors (PI) and reverse transcriptase inhibitors (NRTI, NNRTI). It combines target-specific PCR reagents with in vitro diagnostic software both compatible with either Sanger or Next Generation Sequencing platforms.. Features & Benefits Technology Security
DeepChek® Assay INTEGRASE Genotyping and Drug Resistance Read More »